The CTS investigators reported elevations in risk of ER+/PR+ breast cancers and exposures to acrylamide, benzidine, carbon tetrachloride, ethylidene dichloride, and vinyl choloride and for risk of ER-/PR- breast cancers and benzene. Here, ESR1 is linked to breast carcinoma.